Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma
Authors:
- Shi Yong NeoSNShi Yong Neo
- Timothy Wai Ho ShuenTSTimothy Wai Ho Shuen
- Shruti KhareSKShruti Khare
- Joni ChongJCJoni Chong
- Maichan LauMLMaichan Lau
- Niranjan ShirgaonkarNSNiranjan Shirgaonkar
- Levene ChuaLCLevene Chua
- Junzhe ZhaoJZJunzhe Zhao
- Keene LeeKLKeene Lee
- Charmaine TanCTCharmaine Tan
- Rebecca BaRBRebecca Ba
- Janice LimJLJanice Lim
Open Access
- 25 February 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (7)
Abstract
The functional plasticity of tumor-infiltrating lymphocyte B–cells (TIL-B) spans from antitumor responses to noncanonical immune suppression. Yet, how the tumor microenvironment (TME) influences TIL-B development is still underappreciated. Our current study integrated single-cell transcriptomics and B cell receptor (BCR) sequencing to profile TIL-B phenotypes and clonalities in hepatocellular carcinoma (HCC). Using trajectory and gene regulatory network analysis, we were able to characterize plasma cells and memory and naive B cells within the HCC TME and further revealed a downregulation of BCR signaling genes in plasma cells and a subset of inflammatory TNF + memory B cells. Within the TME, a nonswitched memory B cell subset acquired an age-associated B cell phenotype (TBET + CD11c + ) and expressed higher levels of PD-L1, CD25, and granzyme B. We further demonstrated that the presence of HCC tumor cells could confer suppressive functions on peripheral blood B cells that in turn, dampen T cell costimulation. To the best of our knowledge, these findings represent novel mechanisms of noncanonical immune suppression in HCC. While previous studies identified atypical memory B cells in chronic hepatitis and across several solid cancer types, we further highlighted their potential role as regulatory B cells (Bregs) within both the TME and peripheral blood of HCC patients.Keywords
Funding Information
- National Research Foundation Singapore (NRF-CRP26-2021RS-0001,NRF2017_SISFP09)
- National Medical Research Council (NMRC/OFLCG/003/2018)
- National Medical Research Council (OFIRG24jan-0111)
This publication has 41 references indexed in Scilit:
- B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretionCancer Immunology, Immunotherapy, 2012
- Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infectionsJournal of Hepatology, 2011
- B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesisProceedings of the National Academy of Sciences, 2011
- Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory CellsCancer Research, 2011
- Animal models for hepatitis C and related liver diseaseHepatology Research, 2010
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in miceHepatology, 2004
- B cells regulate autoimmunity by provision of IL-10Nature Immunology, 2002
- Molecular Basis for the Interaction of the Hepatitis B Virus Core Antigen with the Surface Immunoglobulin Receptor on Naive B CellsJournal of Virology, 2001
- Hepatitis B Virus Core Antigen Binds and Activates Naive Human B Cells In Vivo: Studies with a Human PBL-NOD/SCID Mouse ModelJournal of Virology, 2001